Protalix investing

Author: tkrv

August undefined, 2024

WebbProtalix Biotherapeutics, Inc. engages in the development and commercialization of recombinant therapeutic proteins based on ProCellEx plant cell based expression system. It offers Taliglucerase alfa injections under the brand name Elelyso, an enzyme replacement therapy for Gaucher disease. Webb4 juli 2024 · Source: Company Annual Report & estimates, PLX Investor Presentation. The CRL Hiccup. Protalix and Chiesi had submitted the BLA for PRX-102 post its successful completion of Phase 1/2 with the FDA ...

Protalix BioTherapeutics Inc. (PLX) Stock: Evaluating the Annual …

Webb13 apr. 2024 · With the market capitalization of Protalix BioTherapeutics Inc. currently standing at about $135.59 million, investors are eagerly awaiting this quarter’s results, scheduled for May 15, 2024 – May 19, 2024. As a result, investors might want to see an improvement in the stock’s price before the company announces its earnings report. Webb11 apr. 2024 · Protalix BioTherapeutics (NYSE:PLX) has a market capitalization of $126.75 million and generates $47.64 million in revenue each year. The company earns $-14,930,000.00 in net income (profit) each year or ($0.30) on an earnings per share basis. ohio flint ridge

PLX Smart Score - Investing.com

Webb12 apr. 2024 · By Hasnain Raza. April 12, 2024. Protalix BioTherapeutics Inc. (PLX) currently has a stock price of $2.50. The stock saw a sharp increase in the last trading session, hitting a high of $2.35 after opening at $2.30. The lowest recorded price for the day was $2.27 before it closed at $2.35. WebbProvides Protalix Biotherapeutics (PLX) main business data and analysis, including the revenue, costs, and profits of the past years and the latest release. You can query by quarterly, interim, and annual reports。 WebbInvesting.com användarnas resultattavla för Protalix Biotherapeutics Inc aktien. ohio flood 1937

Protalix earnings missed by $0.07, revenue topped estimates - investing…

Home - Protalix Biotherapeutics

Webb11 okt. 2024 · Protalix was the first company to gain U.S. Food and Drug Administration (FDA) approval of a protein produced through plant cell-based in suspension expression system. Protalix's unique expression system represents a new method for developing recombinant proteins in an industrial-scale manner. WebbFå omedelbar tillgång till ett gratis live streamade Protalix Biotherapeutics Inc diagram. ohio flooring marmoleumWebbDenna sida presenterar resultaträkningen (vinst- och förlusträkning) för Protalix Biotherapeutics Inc. Hitta bolagets finansiella resultat, intäkter och mycket mer. ohio flint map

"WebbKassaflödesanalys för Protalix Biotherapeutics Inc, bolagets kassalikviditet, som bryts ner till löpande-, investerings- och finansieringsverksamhet. " - Protalix investing

Protalix investing

WebbProtalix Biotherapeutics Inc (PLX) NYSE Aggiungere uno strumento a: 2,210 + 0,070 ( + 3,27 %) 06/04 - Chiuso. Valuta in USD ( Responsabilità) After Hours 2,240 + 0,030 ( + 1,357 %) 07/04 - Dati... WebbErhåll gratis data i optionskedjan för PLX. Hitta köp- och säljoptioners kurser, slutkurs, förändring, volym, och mer för Protalix Aktieoptioner.

Did you know?

Webb28 mars 2024 · Se finanser, omsättning, kassaflöde, vinst och mer. Nyheter och analyser om aktien. - Protalix aktie idag Stock Screener Sverige ADR:er i världen Sverige-ADR:er … Webb10 feb. 2024 · Investing Groups Leader Follow Summary Shares of plant-derived enzyme therapy concern Protalix BioTherapeutics, Inc. have rallied after its Fabry disease asset PLX-102 received a PDUFA date of...

Webb21 dec. 2024 · Protalix BioTherapeutics, Inc. Dec 21, 2024, 16:30 ET. The Company's Common Stock will continue to trade on the NYSE American. CARMIEL, Israel, Dec. 21, 2024 /PRNewswire/ -- Protalix ... WebbAlla relevanta kommentarer och diskussioner sammanställda om PLX Aktien.

Webb28 mars 2024 · The average price point forecasted by analysts for Protalix BioTherapeutics Inc. (PLX) is $11.00, The public float for PLX is 48.36M, and currently, short sellers hold a 10.65% ratio of that floaft. The average trading volume of PLX on March 28, 2024 was 993.42K shares. PLX) stock’s latest price update Webb27 feb. 2024 · Investing.com - Protalix (NYSE: PLX) reported fourth quarter EPS of $-0.220, $0.07 worse than the analyst estimate of $-0.150. Revenue for the quarter came in at $62.89M versus the consensus...

WebbQuotazione Azioni Protalix in Borsa in tempo reale (ultimo prezzo oggi: 2,470 di NYSE: PLX su NYSE). Potete trovare informazioni sul prezzo, l'andamento e il valore azionario del …

WebbPLX Smart Score - Investing.com Protalix Biotherapeutics Inc (PLX) NYSE Create Alert Add to Watchlist 2.240 +0.030 +1.36% 09:48:35 - Real-time Cboe. Currency in USD ( … my heart rate is 80Webb21 mars 2024 · This table contains core financial ratios such as Price-to-Earnings , Return-On-Investment (ROI), Earnings per share (EPS), Dividend yield and others based on Protalix Biotherapeutics Inc's latest ... ohio floor companyWebbProtalix BioTherapeutics, Inc., a biopharmaceutical company, engages in the development, production, and commercialization of recombinant therapeutic proteins based on its proprietary ProCellEx plant cell-based protein expression system in the United States, Australia, Canada, Israel, Brazil, Russia, Turkey, and internationally. ohio flooringWebbDenna sida innehåller balansräkningen för Protalix Biotherapeutics Inc, som sammanfattar bolagets finansiella ställning, inklusive tillgångar, skulder och mycket mer. Heta nyheter … my heart rate is always above 90Webb27 feb. 2024 · Get the latest Protalix earnings report, revenues and EPS as well as upcoming PLX earnings dates. ohio flint stone ohio flu deaths 2021WebbProtalix Biotherapeutics Inc Interactive Stock Chart (PLX) - Investing.com Free Webinar - Trade timing secrets for success Thursday, February 23, 2024 01:00PM PST Enroll … ohio flooring manufacturers